Clindata^® is an innovative CRO led by the innovative design of innovative drugs. With the explosive growth of innovative drugs in the world, we are committed to helping the new drug research and development services.

As of January 2022, 27 software copyrights have been obtained,involving innovative design, statistical analysis, data management and other fields. Eleven invention patents have been applied for filling the strategic global technology gap and optimizing clinical trial design to improve the success of new drug research and development rate and reduce development costs.